RGDXQ (Response Genetics) Common Stock: $0.00 Mil (As of Dec. 2015)


What is Response Genetics Common Stock?

Response Genetics RGDXQ -98.00% Common Stock is $0.00 Mil as of Dec. 2015.

Response Genetics's quarterly common stock increased from Dec. 2014 ($0.00 Mil) to Mar. 2015 ($0.39 Mil) but then declined from Mar. 2015 ($0.39 Mil) to Dec. 2015 ($0.00 Mil).

Response Genetics's annual common stock declined from Dec. 2013 ($0.34 Mil) to Dec. 2014 ($0.00 Mil) but then stayed the same from Dec. 2014 ($0.00 Mil) to Dec. 2015 ($0.00 Mil).

Response Genetics Common Stock Historical Data

* Premium members only.

The historical data trend for Response Genetics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Response Genetics Common Stock Chart

Response Genetics Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.23 0.34 0.00 0.00

Response Genetics Quarterly Data
Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Dec15
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.39 0.00 0.39 0.00

Response Genetics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.00 Mil mean?
Response Genetics (RGDXQ) has a Common Stock of $0.00 Mil as of Dec. 2015. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Response Genetics and its competitors.
Is Response Genetics' Common Stock too high?
Response Genetics' current Common Stock is $0.00 Mil.
How does Response Genetics' Common Stock compare to PSID and GBSN?
Response Genetics' Common Stock of $0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Diagnostics & Research company?
A good Common Stock depends on the Medical Diagnostics & Research industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Response Genetics and its competitors. Response Genetics's current Common Stock is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Response Genetics stock overvalued right now?
Response Genetics (RGDXQ) has a current Common Stock of $0.00 Mil. The current Common Stock is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Response Genetics (RGDXQ), the current Common Stock is $0.00 Mil as of Dec. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Response Genetics Business Description

Address 201 Route 17 North, 2nd Floor, Rutherford, NJ, USA, 07070
Response Genetics Inc develops and sells diagnostic tests. It provides molecular- and biomarker-based tests and services which enables physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor and inform cancer treatment. The group generates revenue from providing Biopharma Services, Clinical Services, and Discovery Services, of which majority of the revenue is derived from providing Biopharma Services. Biopharma services provide companies with customized solutions for patient stratification and treatment selection through molecular- and biomarker-based testing services, customized assay development and trial design consultation. The firm operates in the US and internationally and generates prime revenue from the US.